Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334,352,960
-
Total 13F shares
-
77,770,935
-
Share change
-
+20,140,784
-
Total reported value
-
$1,312,527,807
-
Put/Call ratio
-
19%
-
Price per share
-
$16.90
-
Number of holders
-
120
-
Value change
-
+$341,021,805
-
Number of buys
-
93
-
Number of sells
-
24
Institutional Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q1 2018
As of 31 Mar 2018 IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) had 120 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 77,770,935 shares of stock of the company.
Largest 10 holders included venBio Select Advisor LLC, PERCEPTIVE ADVISORS LLC, BlackRock Inc., ORBIMED ADVISORS LLC, FRANKLIN RESOURCES INC, ACUTA CAPITAL PARTNERS, LLC, FARALLON CAPITAL MANAGEMENT LLC, GREAT POINT PARTNERS LLC, VANGUARD GROUP INC, and Consonance Capital Management LP.
This table shows 120 institutional shareholders of the security as of 31 Mar 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.